-
Innovation Ranking
NewInnovation Ranking – Takara Bio Inc
Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company develops and researches reagents for genome engineering and analysis, technology used for gene therapy and natural health food products. It offers various medical devices includes analytical reagents, single cell analysis system and genome editing research reagents, among others. Takara services includes instrument services, oem and custom enzyme manufacturing, stem cell services, technical support, shipping and delivery, partnering and licensing and online tools. The company acts as...
-
Innovation Ranking
NewInnovation Ranking – Takara Holdings Inc
Takara Holdings Inc (Takara) is a holding company that coordinates and controls the management of all its group companies. The group comprises Takara Shuzo Group, Takara Bio Group and Takara Healthcare. The Takara Shuzo group offers alcoholic beverages and seasonings; the Takara Bio group develops biomedicals and the Takara Healthcare group provides health foods such as fucoidan, developed with Hokkaido Gagome kombu kelp extracts. Takara offers shochu, sake, light-alcohol refreshers, wine, whisky, Chinese alcoholic beverages, raw alcohol, seasonings, gene, cell...
-
Product Insights
Takara Leben-Nakagawa Solar PV Park
Takara Leben-Nakagawa Solar PV Park is a solar PV project located in Tochigi, Japan. The project is owned and developed by Mirarth Holdings Inc. The project came online in 2016. Empower your strategies with our Takara Leben-Nakagawa Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Company Insights
Innovation and Patenting activity of Takara Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Takara Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Takara Bio Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Takara Bio Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Takara Standard Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Takara Standard Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA Tests market size was $12.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Breast cancer type 1 (BRCA1) and Breast cancer type 1 (BRCA1 gene tests, under the overall umbrella of BRCA Tests) are carried out to detect gene rearrangements within blood samples. The outcome of this may guide therapies and prophylactic actions to treat or prevent certain types of breast and ovarian...
-
Product Insights
Synovial Sarcoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Synovial Sarcoma - Drugs In Development, 2023’, provides an overview of the Synovial Sarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Synovial Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Refractory Chronic Lymphocytic Leukemia (CLL) – Drugs In Development, 2023
Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Drugs In Development, 2023’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Refractory Chronic Lymphocytic Leukemia (CLL), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Relapsed Chronic Lymphocytic Leukemia (CLL) – Drugs In Development, 2023
Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Drugs In Development, 2023’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Relapsed Chronic Lymphocytic Leukemia (CLL), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...